Thrombotic complications of pancreatic cancer: Classical knowledge revisited

Digestive Diseases

Volumn 28, Issue 2, 2010, Pages 350-354

  Dumitrascu, Dan L ^a   Suciu, Ovidiu ^a   Grad, Cosmin ^a   Gheban, Dan ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Deep vein thrombosis; Pancreatic cancer; Pulmonary embolism; Trousseau syndrome

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; LOW MOLECULAR WEIGHT HEPARIN; PROTHROMBIN;

CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CANCER SURGERY; DEEP VEIN THROMBOSIS; GENETIC ASSOCIATION; HUMAN; LUNG EMBOLISM; MUTATION; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; THROMBOSIS;

HUMANS; MASS SCREENING; PANCREATIC NEOPLASMS; PROGNOSIS; THROMBOSIS;

EID: 77956354003     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319413     Document Type: Review

References (18)

1. Trousseau A: Plegmatia alba dolens. Paris, Clinique Medicale de l'Hôtel-Dieu de Paris, Bailliere et Fils, 1865, pp 654-712.
2. Furie B, Furie BC: Mechanisms of thrombus formation. N Engl J Med 2008;359:938-949.
3. Er O, Zacharski L: Management of cancerassociated venous thrombosis. Vasc Health Risk Manag 2006;2:351-356.
4. Blom JW, Doggen CJM, Osanto S, Rosendaal FR: Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005;293:715-772.
5. Nordström M, Lindblad B, Anderson H, Bergqvist D, Kjellström T: Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ 1994;308:891-894.
6. Monreal M, Fernandez-Llamazares J, Perandreu J, Urrutia A, Sahuquillo JC, Contel E: Occult cancer in patients with venous thromboembolism: which patients, which cancers. Thromb Haemost 1997;78:1316-1318.
7. Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, Rimm AA: Rates of initial and recurrent thromboembolic disease among pat ients w it h ma lignanc y versus those without malignancy: risk analysis using Medicare claims data. Medicine 1999;78:285-291.
8. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA: Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000;343:1846-1850.
9. Blom JW, Osanto S, Rosendaal FR: High risk of venous thrombosis in patients with pancreatic cancer: a cohort study of 202 patients. Eur J Cancer 2006;42:410-414.
10. Mitry E, Taleb-Fayad R, Deschamps A, Mansencal N, Lepère C, Declety G, Lièvre A, Vaillant J N, Lesur G, Cramer E, Dubourg O, Rougier P: Risk of venous thrombosis in patients with pancreatic adenocarcinoma. Gastroenterol Clin Biol 2007;31:1139-1142.
11. Khorana AA, Ahrendt SA, Ryan CK, Francis CW, Hruban RH, Hu YC, Hostetter G, Harvey J, Taubman MB: Tissue factor expression, angiogenesis, and thrombosis in pancreat ic cancer. Clin Cancer Res 2007;13:2870-2875.
12. Pihusch R, Danzl G, Scholz M, Harich D, Pihusch M, Lohse P, Hiller E: Impact of thrombophilic gene mutations on thrombosis risk inpatients with gastrointestinal carcinoma. Cancer 2002;94:3120-3126.
13. Alcalay A, Wun T, Khatri V, Chew HK, Harvey D, Zhou H, White RH: Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol 2006;24:1112-1118.
14. Bergqvist D, Agnelli G, Cohen A, Eldor A, Nilsson PE, Le Moigne-Amrani A, Dietrich-Neto F, ENOXACAN II Investigators: Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002;346:975-980.
15. Mismetti P, Laporte S, Darmon JY, Buchmüller A, Decousus H: Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001;88:913-930.
16. Rasmussen MS, Jørgensen LN, Wille-Jørgensen P: Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev 2009;21:CD004318.
17. Arterburn DE, Richardson WS, Murphie AL: Should we look further for cancer in a patient with venous thromboembolism? West J Med 2000;172:325-328.
18. Levine M, Hirsh J: The diagnosis and treatment of thrombosis in the cancer patient. Semin Oncol 1990;17:160-171.